Hassard James - Insider Non-Derivative Transactions at Crinetics Pharmaceuticals, Inc. (CRNX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jul 5, 2024, Hassard James's relationship to Crinetics Pharmaceuticals, Inc. (CRNX) is Officer (Chief Commercial Officer) (Chief Commercial Officer), and currently has 44,259 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CRNX insiders.
Data Source: SEC.
Hassard James - Insider Non-Derivative Transactions of CRNX Common Stock
Hassard James - Insider Non-Derivative Transactions at CRNX
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jul 6, 2024 | Sell -- (Common Stock) | 15,000 | 44.08 | 29,259 |
| Jul 6, 2024 | M -- (Common Stock) | 15,000 | 19.73 | 44,259 |
| Jun 22, 2024 | Sell -- (Common Stock) | 15,000 | 44.66 | 29,259 |
| Jun 22, 2024 | M -- (Common Stock) | 15,000 | 19.73 | 44,259 |
| Mar 19, 2024 | F -- (Common Stock) | 1,741 | 38.14 | 29,259 |
| Mar 5, 2024 | Acquisition -- (Common Stock) | 17,000 | 0 | 31,000 |
| Mar 2, 2023 | Acquisition -- (Common Stock) | 14,000 | 0 | 14,000 |
Items per page:
1 – 7 of 7